---
document_datetime: 2024-08-08 17:43:03
document_pages: 7
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/buvidal-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: buvidal-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 4.4723671
conversion_datetime: 2025-12-19 03:08:39.713688
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## Buvidal

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                               | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary                                                                                                                                  |
|----------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/459/2 02309    | Periodic Safety Update EU Single assessment - buprenorphine (all formulations except implants)                                                      | 30/05/2024                          | 24/07/2024                                  | SmPC, Labelling and PL           | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/459/202309. |
| II/0025              | B.II.d.1.e - Change in the specification parameters and/or limits of the finished product - Change outside the approved specifications limits range | 20/06/2024                          | n/a                                         |                                  |                                                                                                                                          |

1  Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2  A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3  SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IB/0028   | B.II.c.2.d - Change in test procedure for an excipient - Other changes to a test procedure (including replacement or addition)                                                                                                                                                                                                                                                         | 19/06/2024   | n/a        |             |               |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-------------|---------------|
| IB/0027   | B.II.b.5.f - Change to in-process tests or limits applied during the manufacture of the finished product - Addition or replacement of an in-process test as a result of a safety or quality issue                                                                                                                                                                                      | 23/05/2024   | n/a        |             |               |
| IB/0026/G | This was an application for a group of variations. B.II.c.1.a - Change in the specification parameters and/or limits of an excipient - Tightening of specification limits B.II.c.1.a - Change in the specification parameters and/or limits of an excipient - Tightening of specification limits B.II.c.1.z - Change in the specification parameters of an excipient - Other variation | 24/04/2024   | n/a        |             | and/or limits |
| IB/0022   | B.II.e.2.z - Change in the specification parameters and/or limits of the immediate packaging of the finished product - Other variation                                                                                                                                                                                                                                                 | 25/09/2023   | n/a        |             |               |
| IA/0023   | B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                                                                                                                                                            | 18/09/2023   | n/a        |             |               |
| R/0021    | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                                                | 25/05/2023   | 26/07/2023 | SmPC and PL |               |

<div style=\"page-break-after: always\"></div>

| IA/0020/G   | This was an application for a group of variations. B.II.e.2.c - Change in the specification parameters and/or limits of the immediate packaging of the finished product - Deletion of a non-significant specification parameter (e.g. deletion of an obsolete parameter) B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the                                                                                                                                                           | 09/11/2022   | n/a   |              |
|-------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|--------------|
| IB/0019/G   | This was an application for a group of variations. B.II.b.4.a - Change in the batch size (including batch size ranges) of the finished product - Up to 10-fold compared to the originally approved batch size B.II.b.5.a - Change to in-process tests or limits applied during the manufacture of the finished product - Tightening of in-process limits                                                                                                                                                                     | 05/10/2022   | n/a   |              |
| IB/0018/G   | This was an application for a group of variations. B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process B.II.b.5.c - Change to in-process tests or limits applied during the manufacture of the finished product - Deletion of a non-significant in-process test B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process Change in the manufacturing process of | 04/03/2022   | n/a   | B.II.b.3.a - |

<div style=\"page-break-after: always\"></div>

|           | the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |            |            |      |                                      |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------|--------------------------------------|
| IB/0016/G | This was an application for a group of variations. B.II.c.2.d - Change in test procedure for an excipient - Other changes to a test procedure (including replacement or addition) B.II.c.1.b - Change in the specification parameters and/or limits of an excipient - Addition of a new specification parameter to the specification with its corresponding test method B.II.c.2.d - Change in test procedure for an excipient - Other changes to a test procedure (including replacement or addition) B.II.c.1.a - Change in the specification parameters and/or limits of an excipient - Tightening of specification limits B.II.c.1.b - Change in the specification parameters and/or limits of an excipient - Addition of a new specification parameter to the specification with its corresponding test method in control of excipients in the | 05/11/2021 | n/a        |      | B.II.c.z - Change Finished Product - |
| II/0015/G | This was an application for a group of variations. B.II.d.1.e - Change in the specification parameters and/or limits of the finished product - Change outside the approved specifications limits range B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 23/09/2021 | 13/09/2022 | SmPC |                                      |

<div style=\"page-break-after: always\"></div>

|                   | (supported by real time data)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |            |            |                                  |                                                                                                                                          |
|-------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|------------------------------------------------------------------------------------------------------------------------------------------|
| PSUSA/459/2 02007 | Periodic Safety Update EU Single assessment - buprenorphine (all formulations except implants)                                                                                                                                                                                                                                                                                                                                                                                                                   | 25/03/2021 | 19/05/2021 | SmPC and PL                      | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/459/202007. |
| X/0008/G          | This was an application for a group of variations. Annex I_2.(c) Change or addition of a new strength/potency A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites | 25/03/2021 | 19/05/2021 | SmPC, Annex II, Labelling and PL |                                                                                                                                          |
| IAIN/0013/G       | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                                                                                                                                                                     | 27/10/2020 | n/a        |                                  |                                                                                                                                          |
| IB/0012           | B.II.e.2.z - Change in the specification parameters and/or limits of the immediate packaging of the finished product - Other variation                                                                                                                                                                                                                                                                                                                                                                           | 26/10/2020 | n/a        |                                  |                                                                                                                                          |

<div style=\"page-break-after: always\"></div>

| IA/0011   | B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the or addition of a supplier                                                                                                                                                                                                  | 05/10/2020   | n/a        |                                  | dossier) - Replacement   |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|--------------------------|
| IAIN/0010 | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                       | 17/09/2020   | 19/05/2021 | SmPC, Annex II, Labelling and PL |                          |
| IB/0009   | B.II.g.5.b - Implementation of changes foreseen in an approved change management protocol - Requires further supporting data                                                                                                                                                                                         | 08/09/2020   | n/a        |                                  |                          |
| II/0007/G | This was an application for a group of variations. B.II.d.1.e - Change in the specification parameters and/or limits of the finished product - Change outside the approved specifications limits range B.II.f.1.z - Stability of FP - Change in the shelf-life or storage conditions of the finished product - Other | 18/06/2020   | 19/05/2021 | SmPC                             | variation                |
| IB/0006   | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                       | 04/03/2020   | n/a        |                                  |                          |
| II/0005   | B.II.d.1.e - Change in the specification parameters and/or limits of the finished product - Change outside the approved specifications limits range                                                                                                                                                                  | 13/02/2020   | n/a        |                                  |                          |
| IB/0004   | B.II.f.1.z - Stability of FP - Change in the shelf-life or storage conditions of the finished product - Other                                                                                                                                                                                                        | 13/12/2019   | 12/06/2020 | SmPC                             | variation                |

<div style=\"page-break-after: always\"></div>

| IA/0003/G   | This was an application for a group of variations. B.II.d.2.b - Change in test procedure for the finished product - Deletion of a test procedure if an alternative method is already authorised B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer   | 29/11/2019   | n/a        |      |
|-------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------|
| II/0002     | B.II.g.2 - Introduction of a post approval change management protocol related to the finished product                                                                                                                                                                                                                                                                                         | 12/09/2019   | n/a        |      |
| IB/0001     | B.II.f.1.z - Stability of FP - Change in the shelf-life or storage conditions of the finished product - Other variation                                                                                                                                                                                                                                                                       | 21/06/2019   | 12/06/2020 | SmPC |